loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Harpagoside, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Harpagoside

    APIs // Active Pharmaceutical Ingredients

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 19210-12-9, E-harpagoside, 8kgs1dc5zu, Chebi:5625, [(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (e)-3-phenylprop-2-enoate, Smr001233395
    Molecular Formula
    C24H30O11
    Molecular Weight
    494.5  g/mol
    InChI Key
    KVRQGMOSZKPBNS-FMHLWDFHSA-N
    FDA UNII
    8KGS1DC5ZU
    harpagoside is a natural product found in Verbascum lychnitis, Verbascum sinuatum, and other organisms with data available.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
    2.1.2 InChI
    InChI=1S/C24H30O11/c1-23(35-16(27)8-7-13-5-3-2-4-6-13)11-15(26)24(31)9-10-32-22(20(23)24)34-21-19(30)18(29)17(28)14(12-25)33-21/h2-10,14-15,17-22,25-26,28-31H,11-12H2,1H3/b8-7+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1
    2.1.3 InChI Key
    KVRQGMOSZKPBNS-FMHLWDFHSA-N
    2.1.4 Canonical SMILES
    CC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)OC(=O)C=CC4=CC=CC=C4
    2.1.5 Isomeric SMILES
    C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4
    2.2 Other Identifiers
    2.2.1 UNII
    8KGS1DC5ZU
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Harpagophytum Extract Ws 1531

    2. Harpagoside-b

    3. Ws 1531

    4. Ws1531

    2.3.2 Depositor-Supplied Synonyms

    1. 19210-12-9

    2. E-harpagoside

    3. 8kgs1dc5zu

    4. Chebi:5625

    5. [(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (e)-3-phenylprop-2-enoate

    6. Smr001233395

    7. Unii-8kgs1dc5zu

    8. Harpaside

    9. Einecs 242-881-6

    10. Prestwick3_000988

    11. Harpagoside [inci]

    12. Bspbio_001055

    13. Harpagoside [who-dd]

    14. Mls002154086

    15. Mls002473324

    16. Schembl893387

    17. Bpbio1_001161

    18. Chembl516702

    19. Megxp0_000469

    20. Harpagoside, Analytical Standard

    21. Acon0_000056

    22. Acon1_000134

    23. Dtxsid101032528

    24. Hms2098e17

    25. Hms2231n12

    26. Hy-n0396

    27. Zinc8214398

    28. Mfcd00017415

    29. S9171

    30. Akos015896715

    31. Ccg-269650

    32. Lmpr0102070010

    33. Ncgc00179325-01

    34. Ncgc00179325-02

    35. Ncgc00179325-04

    36. Ac-34268

    37. As-56071

    38. Ab00513986

    39. Cs-0008931

    40. C09783

    41. H10494

    42. 210h129

    43. A880338

    44. Q-100231

    45. Brd-k07996107-001-01-7

    46. Brd-k07996107-001-03-3

    47. Harpagoside, Primary Pharmaceutical Reference Standard

    48. Q25099323

    49. Harpagoside, European Pharmacopoeia (ep) Reference Standard

    50. (1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl Cinnamate

    51. (1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl Cinnamate

    52. (1s-(1alpha,4aalpha,5alpha,7alpha(e),7aalpha))-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-d-glucopyranoside

    53. .beta.-d-glucopyranoside, (1s,4as,5r,7s,7as)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-(((2e)-1-oxo-3-phenyl-2-propenyl)oxy)cyclopenta(c)pyran-1-yl

    54. Ncgc00179325-04_c24h30o11_(1s,4as,5r,7s,7as)-1-(beta-d-glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl (2e)-3-phenylacrylate

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 494.5 g/mol
    Molecular Formula C24H30O11
    XLogP3-0.6
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count7
    Exact Mass494.17881177 g/mol
    Monoisotopic Mass494.17881177 g/mol
    Topological Polar Surface Area175 Ų
    Heavy Atom Count35
    Formal Charge0
    Complexity811
    Isotope Atom Count0
    Defined Atom Stereocenter Count10
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY